For a Limited Time: Get 3 Years of Access at the Price of 1
Here is the latest financial fact sheet of REMUS PHARMA. For more details, see the REMUS PHARMA quarterly results and REMUS PHARMA share price.
1 Day | % | 3.5 |
No. of shares | m | 1.47 |
1 Week | % | -3.8 |
1 Month | % | 24.1 |
1 Year | % | - |
52 week H/L | Rs | 8,747.0/1,711.3 |
No. of Mths Year Ending |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
REMUS PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | NA | ||
Low | Rs | NA | NA | NA | NA | ||
Sales per share (Unadj.) | Rs | 11,919.0 | 18,418.0 | 246.9 | 413.1 | ||
Earnings per share (Unadj.) | Rs | 812.0 | 1,026.0 | 34.3 | 78.0 | ||
Diluted earnings per share | Rs | 5.5 | 7.0 | 23.3 | 57.7 | ||
Cash flow per share (Unadj.) | Rs | 918.0 | 1,201.0 | 35.9 | 82.4 | ||
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 2.00 | ||
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 1.48 | ||
Avg Dividend yield | % | 0 | 0 | 0 | 0 | ||
Book value per share (Unadj.) | Rs | 2,020.0 | 3,046.0 | 65.8 | 175.6 | ||
Adj. book value per share | Rs | 13.7 | 20.7 | 44.7 | 129.9 | ||
Shares outstanding (eoy) | m | 0.01 | 0.01 | 1.00 | 1.09 | ||
Price / Sales ratio | x | 0 | 0 | 0 | 0 | ||
Avg P/E ratio | x | 0 | 0 | 0 | 0 | ||
P/CF ratio (eoy) | x | 0 | 0 | 0 | 0 | ||
Price / Book Value ratio | x | 0 | 0 | 0 | 0 | ||
Dividend payout | % | 0 | 0 | 0 | 2.6 | ||
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 0 | ||
Total wages/salary | Rs m | 29 | 30 | 34 | 55 |
REMUS PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 119 | 184 | 247 | 450 | ||
Other income | Rs m | 9 | 8 | 7 | 16 | ||
Total revenues | Rs m | 128 | 192 | 254 | 466 | ||
Gross profit | Rs m | 4 | 8 | 41 | 105 | ||
Depreciation | Rs m | 1 | 2 | 2 | 5 | ||
Interest | Rs m | 0 | 0 | 1 | 2 | ||
Profit before tax | Rs m | 11 | 14 | 46 | 114 | ||
Minority Interest | Rs m | 0 | 0 | 0 | 0 | ||
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | ||
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | ||
Tax | Rs m | 3 | 3 | 12 | 29 | ||
Profit after tax | Rs m | 8 | 10 | 34 | 85 | ||
Gross profit margin | % | 3.3 | 4.1 | 16.7 | 23.4 | ||
Effective tax rate | % | 25.8 | 24.5 | 25.6 | 25.5 | ||
Net profit margin | % | 6.8 | 5.6 | 13.9 | 18.9 |
REMUS PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 48 | 75 | 77 | 113 | ||
Current liabilities | Rs m | 29 | 77 | 92 | 82 | ||
Net working cap to sales | % | 15.4 | -1.0 | -6.0 | 7.1 | ||
Current ratio | x | 1.6 | 1.0 | 0.8 | 1.4 | ||
Inventory Days | Days | 0 | 61 | 116 | 167 | ||
Debtors Days | Days | 498 | 714 | 431 | 393 | ||
Net fixed assets | Rs m | 5 | 35 | 81 | 232 | ||
Share capital | Rs m | 0 | 0 | 10 | 11 | ||
"Free" reserves | Rs m | 20 | 30 | 56 | 181 | ||
Net worth | Rs m | 20 | 30 | 66 | 191 | ||
Long term debt | Rs m | 3 | 2 | 1 | 71 | ||
Total assets | Rs m | 53 | 110 | 158 | 345 | ||
Interest coverage | x | 26.4 | 39.8 | 54.0 | 50.0 | ||
Debt to equity ratio | x | 0.1 | 0.1 | 0 | 0.4 | ||
Sales to assets ratio | x | 2.3 | 1.7 | 1.6 | 1.3 | ||
Return on assets | % | 16.2 | 9.7 | 22.3 | 25.3 | ||
Return on equity | % | 40.2 | 33.7 | 52.2 | 44.4 | ||
Return on capital | % | 49.4 | 43.0 | 70.4 | 44.4 | ||
Exports to sales | % | 0 | 0 | 0 | 0 | ||
Imports to sales | % | 0 | 0 | 2.0 | 1.1 | ||
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | ||
Imports (cif) | Rs m | 0 | 0 | 5 | 5 | ||
Fx inflow | Rs m | 119 | 153 | 232 | 440 | ||
Fx outflow | Rs m | 3 | 2 | 11 | 18 | ||
Net fx | Rs m | 116 | 151 | 220 | 422 |
REMUS PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 13 | 28 | 50 | 53 | ||
From Investments | Rs m | -6 | -31 | -45 | -152 | ||
From Financial Activity | Rs m | 1 | -1 | -2 | 118 | ||
Net Cashflow | Rs m | 8 | -4 | 3 | 19 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Swapnil Jatinbhai Shah | COMP SEC: Deval Bakulkumar Patel | YEAR OF INC: 2015 | NSE CODE: 788377 | FV (Rs): 10 | DIV YIELD (%): 0.0 |
More Trading Company Fact Sheets: SUPREME PETR BHANSALI ENG MANALI PETRO TAMILNADU PETROPRODUCTS VIKAS LIFECARE
Compare REMUS PHARMA With: SUPREME PETR BHANSALI ENG MANALI PETRO TAMILNADU PETROPRODUCTS VIKAS LIFECARE
On Friday, Indian share markets traded on a positive note throughout the trading session and ended higher.